Free shipping on all orders over $ 500

Subasumstat

Cat. No. M9634

All AbMole products are for research use only, cannot be used for human consumption.

Subasumstat Structure
Synonym:

TAK-981

Size Price Availability Quantity
1mg USD 76  USD76 In stock
5mg USD 179  USD179 In stock
10mg USD 279  USD279 In stock
25mg USD 498  USD498 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Subasumstat (TAK-981) is a potent and selective SUMOylation enzymatic cascade inhibitor with potential immune-activating and antineoplastic activities. Subasumstat (TAK-981) targets and covalently binds to the small ubiquitin-like modifier (SUMO; small ubiquitin-related modifier) protein, which prevents the transfer of SUMO from the SUMO-activating enzyme (SAE) to SUMO-conjugating enzyme UBC9. Subasumstat (TAK-981) is able to increase the production of type 1 IFN, thereby increasing type 1 IFN-mediated signaling, activating innate effector cells and enhancing the antitumor innate immune responses.

Chemical Information
Molecular Weight 578.10
Formula C25H28ClN5O5S2
CAS Number 1858276-04-6
Solubility (25°C) DMSO ≥ 18 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Sumit Kumar, et al. Targeting pancreatic cancer by TAK-981: a SUMOylation inhibitor that activates the immune system and blocks cancer cell cycle progression in a preclinical model

[2] Li Du, et al. SUMOylation inhibition enhances dexamethasone sensitivity in multiple myeloma

[3] Antti Kukkula, et al. Therapeutic Potential of Targeting the SUMO Pathway in Cancer

[4] Li Du, et al. Targeting SUMOylation in cancer

[5] Steven P Langston, et al. Discovery of TAK-981, a First-in-Class Inhibitor of SUMO-Activating Enzyme for the Treatment of Cancer

Related E1/E2/E3 Enzyme Products
LS-102

LS-102 is a selective E3 ubiquitin ligase synoviolin (Syvn1) inhibitor. LS-102 inhibits the autoubiquitination of synoviolin with an IC50 of 35 μM.

NX-1607

NX-1607 is an oral, small molecule inhibitor of casitas B-lineage lymphoma proto-oncogene-b (Cbl-b) that has been shown to enhance antigen recall, reduce T cell exhaustion and increase cytokine production upon T cell receptor stimulation, overcoming suppressive signals from the tumor microenvironment (TME).

SENP1-IN-1

SENP1-IN-1 is a specific deSUMOylation protease 1 (SENP1) inhibitor. SENP1-IN-1 can be used for tumor radiosensitivity enhancement.

TRAF6 peptide

TRAF6 peptide is a specific TRAF6-p62 inhibitor.

LTP001

LTP001 is a SMURF1 antagonist that can be used in studies related to idiopathic pulmonary fibrosis (IPF).

  Catalog
Abmole Inhibitor Catalog




Keywords: Subasumstat, TAK-981 supplier, E1/E2/E3 Enzyme, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.